@_katelynatkins @Rad_Nation @Dr_RayMak @subatomicdoc @HinaSaeedMD @BreastDocUK @AmishiBajajMD @merino_tomas @avirupguha I imagine the study was pre-PACIFIC. Could the results (of heart/substructure radiation treatment doses on #CardioTox) be more profou
RT @Cardioncohmm: Cardiovascular Toxicities of Immune Checkpoint Inhibitors: JACC Review... https://t.co/OBwMS2X93v
Cardiovascular Toxicities of Immune Checkpoint Inhibitors https://t.co/MqPGvijsPV
RT @CampbellMDPhD: Physicians need to be aware of 💔toxicity as "we enter an era of cancer therapy dominated by the widespread use of ICIs"…
RT @GuillermoArist8: Toxicidad CV por inhibidores checkpoint: -Miocarditis: 0,25-1,1%. Ocurre a 30 días (16-60). Combinadas: ⬆️5 veces, ⬆️…
Cardiovascular Toxicities of Immune Checkpoint Inhibitors: JACC Review... https://t.co/Em7MX1GkoK
#immunotherapy #toxicity #cardiooncology gran revisión. Listo para la jornada de cardio-oncologia!!! @MariaSolAndres1 #urooncoIAF
Cardiovascular Toxicities of Immune Checkpoint Inhibitors https://t.co/hecVBdAQD3 #lcsm #bcsm
【総説】免疫チェックポイント阻害薬の心血管毒性 https://t.co/YhhjFYNRd0
RT @JACCJournals: #CardioOnc is rapidly evolving! This #JACC review provides a timely update on cardiovascular toxicities of immune checkpo…
Fellows: Add some nuance to "chemotherapy = cardiotoxicity"
RT @JACCJournals: #CardioOnc is rapidly evolving! This #JACC review provides a timely update on cardiovascular toxicities of immune checkpo…
RT @JACCJournals: #CardioOnc is rapidly evolving! This #JACC review provides a timely update on cardiovascular toxicities of immune checkpo…
RT @CampbellMDPhD: Physicians need to be aware of 💔toxicity as "we enter an era of cancer therapy dominated by the widespread use of ICIs"…
RT @CampbellMDPhD: Physicians need to be aware of 💔toxicity as "we enter an era of cancer therapy dominated by the widespread use of ICIs"…
RT @JACCJournals: #CardioOnc is rapidly evolving! This #JACC review provides a timely update on cardiovascular toxicities of immune checkpo…
RT @CampbellMDPhD: Physicians need to be aware of 💔toxicity as "we enter an era of cancer therapy dominated by the widespread use of ICIs"…
RT @JACCJournals: #CardioOnc is rapidly evolving! This #JACC review provides a timely update on cardiovascular toxicities of immune checkpo…
RT @JACCJournals: #CardioOnc is rapidly evolving! This #JACC review provides a timely update on cardiovascular toxicities of immune checkpo…
RT @EuroCardioOnc: @JACCJournals Review Topic of the Week features a superb #CardioOnc paper by #ECOS19 faculty member, Dr Daniel Lenihan (…
RT @CampbellMDPhD: Physicians need to be aware of 💔toxicity as "we enter an era of cancer therapy dominated by the widespread use of ICIs"…
RT @JACCJournals: #CardioOnc is rapidly evolving! This #JACC review provides a timely update on cardiovascular toxicities of immune checkpo…
“Cardiovascular Toxicities of Immune Checkpoint Inhibitors” https://t.co/dO6R10mxU6
RT @datsunian: Great to see more 'mainstream' discussion of ICI related CV toxicities in @JACCJournals by @gcfmd @DLBHATTMD @DLenihanICOS_M…
RT @JACCJournals: #CardioOnc is rapidly evolving! This #JACC review provides a timely update on cardiovascular toxicities of immune checkpo…
RT @JACCJournals: #CardioOnc is rapidly evolving! This #JACC review provides a timely update on cardiovascular toxicities of immune checkpo…
👨🎓👩🎓🔹amazing #JACC review @JACCJournals @TeresaLpezFdez1
RT @JACCJournals: #CardioOnc is rapidly evolving! This #JACC review provides a timely update on cardiovascular toxicities of immune checkpo…
RT @JACCJournals: #CardioOnc is rapidly evolving! This #JACC review provides a timely update on cardiovascular toxicities of immune checkpo…
RT @JACCJournals: #CardioOnc is rapidly evolving! This #JACC review provides a timely update on cardiovascular toxicities of immune checkpo…
RT @JACCJournals: #CardioOnc is rapidly evolving! This #JACC review provides a timely update on cardiovascular toxicities of immune checkpo…
RT @JACCJournals: #CardioOnc is rapidly evolving! This #JACC review provides a timely update on cardiovascular toxicities of immune checkpo…
RT @JACCJournals: #CardioOnc is rapidly evolving! This #JACC review provides a timely update on cardiovascular toxicities of immune checkpo…
RT @JACCJournals: #CardioOnc is rapidly evolving! This #JACC review provides a timely update on cardiovascular toxicities of immune checkpo…
RT @CampbellMDPhD: Physicians need to be aware of 💔toxicity as "we enter an era of cancer therapy dominated by the widespread use of ICIs"…
RT @JACCJournals: #CardioOnc is rapidly evolving! This #JACC review provides a timely update on cardiovascular toxicities of immune checkpo…
RT @JACCJournals: #CardioOnc is rapidly evolving! This #JACC review provides a timely update on cardiovascular toxicities of immune checkpo…
RT @JACCJournals: #CardioOnc is rapidly evolving! This #JACC review provides a timely update on cardiovascular toxicities of immune checkpo…
RT @JACCJournals: #CardioOnc is rapidly evolving! This #JACC review provides a timely update on cardiovascular toxicities of immune checkpo…
RT @JACCJournals: #CardioOnc is rapidly evolving! This #JACC review provides a timely update on cardiovascular toxicities of immune checkpo…
RT @JACCJournals: #CardioOnc is rapidly evolving! This #JACC review provides a timely update on cardiovascular toxicities of immune checkpo…
RT @JACCJournals: #CardioOnc is rapidly evolving! This #JACC review provides a timely update on cardiovascular toxicities of immune checkpo…
RT @JACCJournals: #CardioOnc is rapidly evolving! This #JACC review provides a timely update on cardiovascular toxicities of immune checkpo…
RT @JACCJournals: #CardioOnc is rapidly evolving! This #JACC review provides a timely update on cardiovascular toxicities of immune checkpo…
RT @JACCJournals: #CardioOnc is rapidly evolving! This #JACC review provides a timely update on cardiovascular toxicities of immune checkpo…
#CardioOnc is rapidly evolving! This #JACC review provides a timely update on cardiovascular toxicities of immune checkpoint inhibitors: https://t.co/dvAXPC6xC8 @DLBHATTMD https://t.co/LjTt5FPidJ
“Cardiovascular Toxicities of Immune Checkpoint Inhibitors” https://t.co/cUvj6uLGr2
Physicians need to be aware of 💔toxicity as "we enter an era of cancer therapy dominated by the widespread use of ICIs" Excellent @JACCJournals Review on Immune Checkpoint Inhibitors (ICIs). https://t.co/lxbICaPMh6 #CardioOnc https://t.co/VLCVBvXeK1
RT @EuroCardioOnc: @JACCJournals Review Topic of the Week features a superb #CardioOnc paper by #ECOS19 faculty member, Dr Daniel Lenihan (…
RT @EuroCardioOnc: @JACCJournals Review Topic of the Week features a superb #CardioOnc paper by #ECOS19 faculty member, Dr Daniel Lenihan (…
@JACCJournals Review Topic of the Week features a superb #CardioOnc paper by #ECOS19 faculty member, Dr Daniel Lenihan (@DLenihanICOS_MD). Physicians should be aware of the rare but potentially fatal cardiovascular toxicities associated with #immunotherapy
RT @Dr_Iakobishvili: Excellent overview and expands the scope. Probably not so rare but under recognized and under reported. Trsoponin is n…
Excellent overview and expands the scope. Probably not so rare but under recognized and under reported. Trsoponin is not cost effective for routine screening but probably compared to mandatory following 12 weeks ec
RT @SeanM_Wu: Nice article! @HanZhuMD & I have recently started troponin surveillance on @StanfordMed ICI pts and the rate of asyptomatic s…
RT @DLBHATTMD: Cardiovascular Toxicities of Immune Checkpoint Inhibitors https://t.co/kJoN9QhITY
RT @DLBHATTMD: Cardiovascular Toxicities of Immune Checkpoint Inhibitors https://t.co/kJoN9QhITY
RT @Tatsu_Miyoshi: This week's JACC includes the review in cardiotoxicities in ICIs. I have not read it yet, but it would be worth reading…
RT @datsunian: Great to see more 'mainstream' discussion of ICI related CV toxicities in @JACCJournals by @gcfmd @DLBHATTMD @DLenihanICOS_M…
RT @OSUCardioOnc: Cardiovascular Toxicities of Immune Checkpoint Inhibitors https://t.co/A8loceSTcV #CardioOnc @ICOSociety @EuroCardioOnc h…
RT @CardiOncoSAC: Immune checkpoint inhibitors !! 👀 https://t.co/k0wmosmdUe
RT @sarahhudsonuk: Immune checkpoint inhibitors (Eg ipilimumab) and the ♥️: 🔹multiple CV side effects possible 🔹commonest is myocarditis (…
RT @datsunian: Great to see more 'mainstream' discussion of ICI related CV toxicities in @JACCJournals by @gcfmd @DLBHATTMD @DLenihanICOS_M…
RT @CardioSix: Immune Check Inhibitors, used in adjuvant cancer therapy, have a multitude of cardiovascular adverse events. https://t.co/JN…
Immune Check Inhibitors, used in adjuvant cancer therapy, have a multitude of cardiovascular adverse events. https://t.co/JNemS8UL7I Give #five4six to #Cardio6 #mHealth #WearableTech #MedicalDevices #SaveLives
RT @JTLLERGO: Cardiovascular Toxicities of Immune Checkpoint Inhibitors: JACC Review @JACCJournals @secardiologia @SACardiologia @MesaLola…
RT @DLBHATTMD: Cardiovascular Toxicities of Immune Checkpoint Inhibitors https://t.co/kJoN9QhITY
RT @JTLLERGO: Cardiovascular Toxicities of Immune Checkpoint Inhibitors: JACC Review @JACCJournals @secardiologia @SACardiologia @MesaLola…
RT @CardiOncoSAC: Immune checkpoint inhibitors !! 👀 https://t.co/k0wmosmdUe
Immune checkpoint inhibitors !! 👀
RT @datsunian: Great to see more 'mainstream' discussion of ICI related CV toxicities in @JACCJournals by @gcfmd @DLBHATTMD @DLenihanICOS_M…
RT @sarahhudsonuk: Immune checkpoint inhibitors (Eg ipilimumab) and the ♥️: 🔹multiple CV side effects possible 🔹commonest is myocarditis (…
RT @SeanM_Wu: Nice article! @HanZhuMD & I have recently started troponin surveillance on @StanfordMed ICI pts and the rate of asyptomatic s…
RT @sarahhudsonuk: Immune checkpoint inhibitors (Eg ipilimumab) and the ♥️: 🔹multiple CV side effects possible 🔹commonest is myocarditis (…
RT @SeanM_Wu: Nice article! @HanZhuMD & I have recently started troponin surveillance on @StanfordMed ICI pts and the rate of asyptomatic s…
RT @datsunian: Great to see more 'mainstream' discussion of ICI related CV toxicities in @JACCJournals by @gcfmd @DLBHATTMD @DLenihanICOS_M…
RT @datsunian: Great to see more 'mainstream' discussion of ICI related CV toxicities in @JACCJournals by @gcfmd @DLBHATTMD @DLenihanICOS_M…
RT @JTLLERGO: Cardiovascular Toxicities of Immune Checkpoint Inhibitors: JACC Review @JACCJournals @secardiologia @SACardiologia @MesaLola…
RT @DLBHATTMD: Cardiovascular Toxicities of Immune Checkpoint Inhibitors https://t.co/kJoN9QhITY
An increasingly recognised problem - diagnosed more by oncologists than cardiologists. We need to educate ourselves!
RT @datsunian: Great to see more 'mainstream' discussion of ICI related CV toxicities in @JACCJournals by @gcfmd @DLBHATTMD @DLenihanICOS_M…
ICI and cardiovascular toxicities : not only myocarditis. A review from Dr Ball and D Bhatt, this week in JACC Toxicities of Immune Checkpoint Inhibitors https://t.co/vHoIPwhyxG
RT @sarahhudsonuk: Immune checkpoint inhibitors (Eg ipilimumab) and the ♥️: 🔹multiple CV side effects possible 🔹commonest is myocarditis (…
RT @sarahhudsonuk: Immune checkpoint inhibitors (Eg ipilimumab) and the ♥️: 🔹multiple CV side effects possible 🔹commonest is myocarditis (…
Immune checkpoint inhibitors (Eg ipilimumab) and the ♥️: 🔹multiple CV side effects possible 🔹commonest is myocarditis (~1%) 🔹mortality of myocarditis ~50% 🔹Rx is high dose steroids Review in @JACCJournals by @DLBHATTMD Link: https://t.co/wTSOZ0z7r0 #
RT @OSUCardioOnc: Cardiovascular Toxicities of Immune Checkpoint Inhibitors https://t.co/A8loceSTcV #CardioOnc @ICOSociety @EuroCardioOnc h…
RT @datsunian: Great to see more 'mainstream' discussion of ICI related CV toxicities in @JACCJournals by @gcfmd @DLBHATTMD @DLenihanICOS_M…
RT @DLBHATTMD: Cardiovascular Toxicities of Immune Checkpoint Inhibitors https://t.co/kJoN9QhITY
RT @SeanM_Wu: Nice article! @HanZhuMD & I have recently started troponin surveillance on @StanfordMed ICI pts and the rate of asyptomatic s…
RT @DLBHATTMD: Cardiovascular Toxicities of Immune Checkpoint Inhibitors https://t.co/kJoN9QhITY
Nice article! @HanZhuMD & I have recently started troponin surveillance on @StanfordMed ICI pts and the rate of asyptomatic significantly positive is higher than expected. Suspect the same will be seen elsewhere. @CardioOncology @Ron_Witteles @Dr_Mike_
RT @DLBHATTMD: Cardiovascular Toxicities of Immune Checkpoint Inhibitors https://t.co/kJoN9QhITY
Cardiovascular Toxicities of Immune Checkpoint Inhibitors https://t.co/A8loceSTcV #CardioOnc @ICOSociety @EuroCardioOnc https://t.co/jZZ3brdegH
RT @JTLLERGO: Cardiovascular Toxicities of Immune Checkpoint Inhibitors: JACC Review @JACCJournals @secardiologia @SACardiologia @MesaLola…
RT @DLBHATTMD: Cardiovascular Toxicities of Immune Checkpoint Inhibitors https://t.co/kJoN9QhITY
If you are starting career in academic cardiology, this is dream come true. Our first publication in JACC main, under mentorship of Profs. Bhatt, Fonarow, and Lenihan. Immune checkpoint inhibitors are revolutionizing cancer managem…https://t.co/0yDn3s3mEJ
RT @dhrubajyoti1: Thanks a lot @DLBHATTMD @gcfmd https://t.co/ihSCDHMm3e